|
|
| (39 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
| Zeile 1: |
Zeile 1: |
| | __NOTOC__ | | __NOTOC__ |
| | *'''[[Further reading]]''' | | *'''[[Further reading]]''' |
| − | *'''[[Unproven ideas]]'''
| |
| − | *'''[[Reviews on covid19 disease]]'''
| |
| | | | |
| | | | |
| | + | *'''[[Unproven ideas]]''' |
| | | | |
| | + | *'''[[Reviews on covid19 disease]]''' |
| | *'''[[Clinical guidelines and advice]]''' | | *'''[[Clinical guidelines and advice]]''' |
| − | {{tp|p=C7149288|t=2020. Empfehlungen zur intensivmedizinischen Therapie von Patienten mit COVID-19* |pdf=|usr=}}
| + | |
| − | {{tp|p=C7162768|t=2020. Therapeutic management of patients with COVID-19: a systematic review |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | *'''[[Respiration mgmt]]''' | | *'''[[Respiration mgmt]]''' |
| − | {{tp|p=C7203031|t=ä. Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection? |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (Laboratory)]]''' | | *'''[[Diagnosis (Laboratory)]]''' |
| − | {{tp|p=C7200353|t=2020. A nanoparticle pseudo pathogen for rapid detection and diagnosis of virus infection |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=C7203047|t=ä. Imagerie de la pneumonie COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7175452|t=ä. Deep learning system to screen coronavirus disease 2019 pneumonia |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (other modalities)]]''' | | *'''[[Diagnosis (other modalities)]]''' |
| | | | |
| | | | |
| − | ----
| |
| | | | |
| | | | |
| | *'''[[Structure of covid19]]''' | | *'''[[Structure of covid19]]''' |
| − | *'''[[Target binding and uptake]]'''
| |
| | | | |
| | + | |
| | + | *'''[[Target binding and uptake]]''' |
| | *'''[[Cytopathic effects]]''' | | *'''[[Cytopathic effects]]''' |
| | *'''[[Secretion and shedding]]''' | | *'''[[Secretion and shedding]]''' |
| Zeile 47: |
Zeile 38: |
| | | | |
| | | | |
| − | ----
| |
| − | *'''[[Pathobiology]]'''
| |
| − | {{tp|p=C7173822|t=2020. Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Pathobiology]]''' |
| | | | |
| | | | |
| | *'''[[Disease Models]]''' | | *'''[[Disease Models]]''' |
| − |
| |
| | | | |
| | | | |
| | *'''[[Similar diseases and pathomechanisms]]''' | | *'''[[Similar diseases and pathomechanisms]]''' |
| | + | |
| | | | |
| | | | |
| Zeile 66: |
Zeile 55: |
| | | | |
| | *'''[[Co-Infection]]''' | | *'''[[Co-Infection]]''' |
| − | {{tp|p=C7195315|t=2020. Co-infections: potentially lethal and unexplored in COVID-19 |pdf=|usr=}}
| + | |
| | | | |
| | *'''[[Pulmonary embolism, coagulation]]''' | | *'''[[Pulmonary embolism, coagulation]]''' |
| | + | |
| | + | |
| | + | |
| | + | |
| | | | |
| | *'''[[Hematology]]''' | | *'''[[Hematology]]''' |
| Zeile 79: |
Zeile 72: |
| | | | |
| | *'''[[Neurology, ophthalmology, orl]]''' | | *'''[[Neurology, ophthalmology, orl]]''' |
| − | {{tp|p=C7200324|t=ä. SARS-CoV-2 infection associated with diplopia and anti-acetylcholine receptor antibodies? |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| | + | |
| | | | |
| | | | |
| | *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
| − | {{tp|p=C7198139|t=2020. Suspected Acute Abdomen as an Extrapulmonary Manifestation of Covid-19 Infection? |pdf=|usr=}}
| |
| − | {{tp|p=C7180357|t=ä. Beware: Gastrointestinal symptoms can be a manifestation of COVID-19? |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Kidney, urology]]''' | | *'''[[Kidney, urology]]''' |
| | | | |
| − | | + | *'''[[The morbid survivor]]''' |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=C7197241|t=2020. ACEI inhibitors and ARBs do not increase severity of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7183935|t=ä. Status of SARS-CoV-2 infection in patients on renal replacement therapy Report of the COVID-19 Registry of the Spanish Society of Nephrology (SEN)? |pdf=|usr=}}
| |
| − | {{tp|p=C7194925|t=2020. ... COVID-19 para el paciente con insuficiencia cardiaca, trasplante cardiaco y asistencia ventricular ... |pdf=|usr=}}
| |
| − | {{tp|p=C7158793|t=2020. Neonatal COVID?19: little evidence and the need for more information? |pdf=|usr=}}
| |
| | | | |
| | | | |
| − | *'''[[The morbid survivor]]'''
| |
| | | | |
| | *'''[[Case reports]]''' | | *'''[[Case reports]]''' |
| Zeile 108: |
Zeile 93: |
| | | | |
| | | | |
| − | *'''[[Case series]]'''
| |
| − | {{tp|p=C7165248|t=2020. Auch Kinder können schwer an COVID-19 erkranken |pdf=|usr=}}
| |
| − | *'''[[Registries]]'''
| |
| − | ----
| |
| | | | |
| | | | |
| − | *'''[[Trials]]'''
| |
| | | | |
| | | | |
| | + | *'''[[Case series]]''' |
| | | | |
| − | *'''[[Candidate Compounds Covid19]]'''
| |
| − | {{tp|p=C7203037|t=ä. (Vitamin-C; Ozone)Two known therapies could be useful as adjuvant therapy in critical patients infected by COVID-19? |pdf=|usr=}}
| |
| − | {{tp|p=C7197234|t=2020. Safety concerns with higher dosage chloroquine in COVID-19 patients |pdf=|usr=}}
| |
| − | {{tp|p=C7197245|t=2020. Antimalarial use in COVID-19 patients requires close monitoring |pdf=|usr=}}
| |
| − | {{tp|p=C7180667|t=ä. Achilles heel of the killer virus: the highly important molecular targets for hitting SARS-CoV-2 that causes COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7190525|t=2020. Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients |pdf=|usr=}}
| |
| | | | |
| | + | *'''[[Registries]]''' |
| | | | |
| | | | |
| | + | *'''[[Trials]]''' |
| | | | |
| | + | *'''[[Candidate Compounds Covid19]]''' |
| | | | |
| | | | |
| | + | *'''[[Other routes of infection]]''' |
| | | | |
| | | | |
| − | *'''[[Other routes of infection]]''' | + | *'''[[Biophysics of aerosols]]''' |
| | | | |
| | | | |
| | | | |
| − | *'''[[Biophysics of aerosols]]'''
| |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − |
| |
| − | *'''[[Running your hospital]]'''
| |
| − | {{tp|p=C7198218|t=ä. Practical recommendations for the perioperative management of the patient with suspection or serious infection by coronavirus SARS-CoV? |pdf=|usr=}}
| |
| − | {{tp|p=C7198147|t=ä. Recomendaciones en reanimaci�n cardiopulmonar en pacientes con COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7196403|t=2020. Surgical Management of Patients With COVID-19 Infection Recommendations of the Spanish Association of Surgeons? |pdf=|usr=}}
| |
| − | {{tp|p=C7186769|t=ä. Access Denied: Academic Life Under Lockdown |pdf=|usr=}}
| |
| − | {{tp|p=C7186212|t=ä. Resumption of activity in gastroenterology departments Recommendations by SEPD, AEEH, GETECCU and AEG? |pdf=|usr=}}
| |
| − | {{tp|p=C7160435|t=2020. Neurologie in Zeiten von COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7180676|t=2020. The COVID-19 Pandemic and Implications for Gynaecologic Cancer Care |pdf=|usr=}}
| |
| − | {{tp|p=C7177056|t=ä. Management of neurological care during the COVID-19 pandemic? |pdf=|usr=}}
| |
| − | {{tp|p=C7176377|t=ä. COVID-19 et Chirurgie ORL |pdf=|usr=}}
| |
| − | {{tp|p=C7171436|t=ä. Intelligent technologies help operating mobile cabin hospitals effectively cope with COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7168570|t=ä. Coronavirus-Pandemie und ihre Auswirkungen auf Orthop�die und Unfallchirurgie: Operationen, Risiken und Pr�vention?|pdf=|usr=}}
| |
| − | {{tp|p=C7167575|t=ä. ... laryngologie et en phoniatrie ...|pdf=|usr=}}
| |
| − | {{tp|p=C7149297|t=2020. Auswirkungen auf nerven�rztliche, neurologische, psychiatrische Praxen |pdf=|usr=}}
| |
| − | {{tp|p=C7158839|t=ä. Management of the SARS-CoV-2 (COVID-19) coronavirus epidemic in hemodialysis units? |pdf=|usr=}}
| |
| | | | |
| | | | |
| | | | |
| | + | *'''[[Running your hospital]]''' |
| | | | |
| | | | |
| | *'''[[Mental aspects of health professionals]]''' | | *'''[[Mental aspects of health professionals]]''' |
| − |
| |
| | | | |
| | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' | | *'''[[Socio-psychiatric aspects of the status hygienicus]]''' |
| | + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Avoiding clinical medicine in other diseases]]''' | | *'''[[Avoiding clinical medicine in other diseases]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Occupational medicine, workplace security and status hygienicus]]''' | | *'''[[Occupational medicine, workplace security and status hygienicus]]''' |
| Zeile 173: |
Zeile 138: |
| | | | |
| | *'''[[Economic aspects of the status hygienicus]]''' | | *'''[[Economic aspects of the status hygienicus]]''' |
| − | {{tp|p=C7197568|t=ä. COVID-19 and the Future of Microfinance: Evidence and Insights from Pakistan |pdf=|usr=}}
| |
| − | {{tp|p=C7193138|t=ä. If Everything Has Changed, Why Such a Focus on Bailing Out Capitalism? The Somber Reality Underpinning Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7191284|t=2020. The COVID-19 pandemic: Considerations for the waste and wastewater services sector |pdf=|usr=}}
| |
| − | {{tp|p=C7183981|t=2020. Startups in times of crisis ? A rapid response to the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=C7183942|t=ä. How the COVID-19 Pandemic May Change the World of Retailing |pdf=|usr=}}
| |
| − | {{tp|p=C7194614|t=2020. Estimating the COVID-19 cash crunch: Global evidence and policy? |pdf=|usr=}}
| |
| − | {{tp|p=C7173828|t=2020. Impact on biometrics of Covid-19 |pdf=|usr=}}
| |
| − | {{tp|p=C7160643|t=ä. Financial markets under the global pandemic of COVID-19 |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | | | |
| Zeile 194: |
Zeile 149: |
| | | | |
| | *'''[[Epidemiology]]''' | | *'''[[Epidemiology]]''' |
| − | {{tp|p=C7201389|t=ä. Modelling COVID-19 |pdf=|usr=}}
| + | |
| − | {{tp|p=C7197617|t=ä. Six Feet Apart: Lessons Learned from COVID-19 and Social Distancing |pdf=|usr=}}
| + | |
| − | {{tp|p=C7182510|t=2020. Managing disasters amid COVID-19 pandemic: Approaches of response to flood disasters |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| | | | |
| | *'''[[Remission, recurrence and persistence]]''' | | *'''[[Remission, recurrence and persistence]]''' |
| | + | |
| | + | |
| | | | |
| | *'''[[Failure of executive measures]]''' | | *'''[[Failure of executive measures]]''' |
| | ---- | | ---- |
| | *'''[[Failure of politics and public health guidance]]''' | | *'''[[Failure of politics and public health guidance]]''' |
| − |
| |
| | | | |
| | | | |
| Zeile 220: |
Zeile 175: |
| | | | |
| | *'''[[History of covid19 exploration]]''' | | *'''[[History of covid19 exploration]]''' |
| − | {{tp|p=C7147143|t=2020. Zwischen Infektionsschutz und Versorgungsauftrag: Eine Zwischenbilanz vier Wochen nach Ausbruch der Pandemie |pdf=|usr=}}
| + | *'''[[misc.]]''' |
| | | | |
| | | | |
| − | *'''[[misc.]]''' | + | *'''[[Research tools]]''' |
| − | {{tp|p=C7195908|t=ä. Editor?s Note: Applied Intelligence and COVID-19 Research |pdf=|usr=}}
| + | |
| − | {{tp|p=C7160436|t=2020. Das Gesundheitssystem muss resilienter werden |pdf=|usr=}}
| + | |
| − | {{tp|p=C7147196|t=2020. Ambulante Versorgung in der Corona-Krise: Gro�teil der COVID-19-Patienten wird in den Praxen behandelt |pdf=|usr=}}
| + | |
| − | {{tp|p=C7149296|t=2020. COVID-19: Risikoabsch�tzung und Planungsgrundlagen f�r unsere Praxen |pdf=|usr=}}
| + | |
| − | {{tp|p=C7160816|t=ä. Aufkl�rung bald nur noch via Skype?!: Zu den M�glichkeiten und Grenzen der Fernaufkl�rung |pdf=|usr=}}
| + | |
| | | | |
| | | | |
| − | *'''[[Research tools]]''
| + | |
| | + | |
| | + | {{tp|p=27490990|t=2017. AVCpred: an integrated web server for prediction and design of antiviral compounds |pdf=|usr=}} |
| | + | {{tp|p=25040500|t=2014. Engineering large viral DNA genomes using the CRISPR?Cas9 system |pdf=|usr=}} |
| | + | |
| | | | |
| | *'''[[PrePrint scene]]''' | | *'''[[PrePrint scene]]''' |
| | + | |
| | | | |
| | *'''[[from the ads]]''' | | *'''[[from the ads]]''' |
| | + | |
| | *'''[[Current state of coviki.org]]''' | | *'''[[Current state of coviki.org]]''' |
| | *'''[[on-topic personal thoughts]]''' | | *'''[[on-topic personal thoughts]]''' |
